Alerts will be sent to your verified email
Verify Email
NORRIS
|
Norris Medicines
|
Chemo Pharma Labs
|
Shamrock Indl. Co
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
47.03 % | -4.51 % | -8.9 % |
|
5yr average Equity Multiplier
|
-2.46 | 1.01 | 1.02 |
|
5yr Average Asset Turnover Ratio
|
0.6 | 0.0 | 0.0 |
|
5yr Avg Net Profit Margin
|
-30.66 % | 0.0 | 0.0 |
|
Price to Book
|
0.0 | 1.29 | 11.22 |
|
P/E
|
0.0 | 50.16 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
97.28 Days | 0.0 | 0.0 |
|
Inventory Days
|
165.43 Days | 0.0 | 0.0 |
|
Days Receivable
|
69.98 Days | 0.0 | 0.0 |
|
Days Payable
|
260.51 Days | 0.0 | 68.55 Days |
|
5yr Average Interest Coverage Ratio
|
-1.37 | 794.39 | 0.0 |
|
5yr Avg ROCE
|
-19.87 % | -3.17 % | -8.89 % |
|
5yr Avg Operating Profit Margin
|
-6.94 % | 0.0 | 0.0 |
|
5 yr average Debt to Equity
|
-3.0 | 0.01 | 0.0 |
|
5yr CAGR Net Profit
|
-15.97 % | n/a | -28.89 % |
|
5yr Average Return on Assets
|
-18.92 % | -4.13 % | -8.72 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
34.0 % | 27.89 % | 42.98 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.04 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Norris Medicines
|
Chemo Pharma Labs
|
Shamrock Indl. Co
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|